Table 4.
Characteristic | Event | Death | ||||||
---|---|---|---|---|---|---|---|---|
3 years | 5 years | 3 years | 5 years | |||||
No | Yes | No | Yes | No | Yes | No | Yes | |
n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | |
Sex | ||||||||
Male | 99 (59.3) | 68 (40.7) | 89 (53.3) | 78 (46.7) | 119 (71.3) | 48 (28.7) | 113 (67.7) | 54 (32.3) |
Female | 78 (57.8) | 57 (42.2) | 72 (53.3) | 63 (46.7) | 91 (67.4) | 44 (32.6) | 83 (61.5) | 52 (38.5) |
Age (years) | ||||||||
<1 | 0 (0) | 1 (100) | 0 (0) | 1 (100) | 1 (100) | 0 (100) | 0 (0) | 1 (100) |
1–5 | 79 (64.8) | 43 (35.2) | 71 (58.2) | 51 (41.8) | 93 (76.2) | 29 (23.8) | 87 (71.3) | 35 (28.7) |
5.1–9.99 | 35 (53.0) | 31 (47.0) | 32 (48.5) | 34 (51.5) | 44 (66.7) | 22 (33.3) | 40 (60.6) | 26 (39.4) |
≥10 | 63 (55.8) | 50 (44.2) | 58 (51.3) | 55 (48.7) | 72 (63.7) | 41 (36.3) | 69 (61.1) | 44 (38.9) |
Immunophenotype | ||||||||
B | 166 (59.5) | 113 (40.5) | 150 (53.8) | 129 (46.2) | 198 (71.0) | 81 (29.0) | 185 (66.3) | 94 (33.7) |
T | 11 (47.8) | 12 (52.2) | 11 (47.8) | 12 (52.2) | 12 (52.2) | 11 (47.8) | 11 (47.8) | 12 (52.2) |
WBC count (1 × 109/L) | ||||||||
<10 | 91 (61.9) | 56 (38.1) | 87 (59.2) | 60 (40.8) | 107 (72.8) | 40 (27.2) | 104 (70.7) | 43 (29.3) |
10–20 | 26 (54.2) | 22 (45.8) | 21 (43.8) | 27 (56.3) | 30 (62.5) | 18 (37.5) | 28 (58.3) | 20 (41.7) |
20–50 | 20 (58.8) | 14 (41.2) | 18 (52.9) | 16 (47.1) | 23 (67.6) | 11 (32.4) | 22 (64.7) | 12 (35.3) |
50–100 | 17 (63.0) | 10 (37.0) | 16 (59.3) | 11 (40.7) | 21 (77.8) | 6 (22.2) | 17 (63.0) | 10 (37.0) |
>100 | 23 (50.0) | 23 (50.0) | 19 (41.3) | 27 (58.7) | 29 (63.0) | 17 (37.0) | 25 (54.3) | 21 (45.7) |
Risk group | ||||||||
Standard | 84 (57.5) | 62 (42.5) | 76 (52.1) | 70 (47.9) | 102 (69.9) | 44 (30.1) | 98 (67.1) | 48 (32.9) |
High | 93 (59.6) | 63 (40.4) | 85 (54.3) | 71 (45.5) | 108 (69.2) | 48 (30.8) | 98 (62.8) | 58 (37.2) |